Advertisement
Study identifies a cohort of low-risk patients, finds LVEF predicts late VT/VF in those at higher risk
Procedure allows for safer epicardial VT mapping and ablation
Study finds that in the absence of ACS, the yield is low and outcomes are unaffected
Further study needed to assess potential role in select subgroups
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New technology aids a Cleveland Clinic London patient with a complex arrhythmia
After optimized medical and device therapy, is there a role for endocardial-epicardial VT ablation?
Device integrates wireless communication between leadless pacing and ICD therapy
How we’re using a new multidisciplinary approach to broaden the benefits of ablation
Cleveland Clinic experience demonstrates viability in a high-risk population
Pushing the envelope in ablation of atrial fibrillation, ventricular tachycardia
Advertisement
Advertisement